Newland Pharmaceutical Co., Ltd. (SHE:301277)
10.47
+0.15 (1.45%)
At close: Sep 30, 2026
Newland Pharmaceutical Market Cap
Newland Pharmaceutical has a market cap or net worth of 4.11 billion as of October 2, 2026. Its market cap has decreased by -17.62% in one year.
Market Cap
4.11B
Enterprise Value
3.49B
Revenue
710.55M
Ranking
n/a
PE Ratio
39.38
Stock Price
10.47
ChartMarket Cap Chart
Since November 16, 2022, Newland Pharmaceutical's market cap has decreased from 5.31B to 4.11B, a decrease of -22.66%. That is a compound annual growth rate of -6.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 4.11B | -11.20% |
| Dec 31, 2025 | 4.62B | 19.35% |
| Dec 31, 2024 | 3.87B | -6.96% |
| Dec 29, 2023 | 4.16B | 8.12% |
| Dec 30, 2022 | 3.85B | -27.46% |
| Nov 16, 2022 | 5.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding